Financial statements Biodefol
Balance sheet data of BIODEFOL
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 499 196,25 | 2 308 829,09 | 9 877 004,03 | 8 972 021,72 | 8 962 446,53 | 8 229 061,22 |
| A. Fixed assets | 374 943,89 | 388 719,63 | 7 743 615,11 | 7 191 907,85 | 6 671 251,93 | 6 102 946,57 |
| B. Current assets | 124 252,36 | 1 920 109,46 | 2 133 388,92 | 1 780 113,87 | 2 291 194,60 | 2 126 114,65 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 499 196,25 | 2 308 829,09 | 9 877 004,03 | 8 972 021,72 | 8 962 446,53 | 8 229 061,22 |
| A. Equity | 498 836,85 | 2 307 118,13 | 2 506 423,04 | 2 530 627,57 | 2 876 302,31 | 3 009 201,95 |
| B. Liabilities and provisions for liabilities | 359,40 | 1 710,96 | 7 370 580,99 | 6 441 394,15 | 6 086 144,22 | 5 219 859,27 |
| I. Long-term liabilities | - | - | 920 185,13 | 735 467,63 | 646 485,13 | 552 645,13 |
| II. Short-term liabilities | 359,40 | 1 710,96 | 1 694 045,01 | 1 295 607,43 | 1 375 371,76 | 948 958,57 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.